{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:15:32Z","timestamp":1776312932147,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.neuro.2005.04.005","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T15:47:16Z","timestamp":1118418436000},"page":"945-957","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Phospholipid Methylation in 1-Methyl-4-Phenyl-Pyridinium Ion (MPP+)-Induced Neurotoxicity in PC12 Cells"],"prefix":"10.1016","volume":"26","author":[{"given":"Eun-Sook Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clivel G.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam F.A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2005.04.005_bib1","first-page":"399","article-title":"Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids","volume":"288","author":"Abu-Raya","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2005.04.005_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0304-3940(00)01723-7","article-title":"Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease","volume":"298","author":"Aoyama","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2005.04.005_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020070047","article-title":"N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test","volume":"107","author":"Aoyama","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2005.04.005_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1022464421655","article-title":"Striatal and urinary DOPAC\/DA ratio indicate a long-lasting DA release enhancement by MPP+ and MPTP","volume":"23","author":"Bagchi","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2005.04.005_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0024-3205(85)90063-3","article-title":"Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"36","author":"Castagnoli","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2005.04.005_bib7","first-page":"333","article-title":"A parallel relationship between Parkinson's disease and an excess of S-adenosylmethionine-dependent biological methylation in the brain","volume":"vol. 1","author":"Charlton","year":"1990"},{"key":"10.1016\/j.neuro.2005.04.005_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02816115","article-title":"Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain","volume":"9","author":"Charlton","year":"1994","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuro.2005.04.005_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.2042-7158.1978.tb13408.x","article-title":"Tremor induced by S-adenosyl-l-methionine: possible relation to l-dopa effects","volume":"30","author":"Charlton","year":"1978","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01271538","article-title":"MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57\/Bl6 mice","volume":"100","author":"Chen","year":"1995","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuro.2005.04.005_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1476-5381.1995.tb13229.x","article-title":"Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter","volume":"114","author":"Clarke","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","article-title":"Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement","volume":"58","author":"Cleeter","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-2275(20)33425-8","article-title":"Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events","volume":"41","author":"Colles","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.1980.tb11229.x","article-title":"Identification and properties of methyltransferases that synthesize phosphatidylcholine in rat brain synaptosomes","volume":"34","author":"Crews","year":"1980","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0163-1047(93)90950-M","article-title":"S-Adenosyl-l-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms","volume":"59","author":"Crowell","year":"1993","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.neuro.2005.04.005_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/nbdi.1998.0192","article-title":"Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis","volume":"5","author":"Fu","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2005.04.005_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1027351120616","article-title":"Characterization of brain b-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease","volume":"22","author":"Gearhart","year":"1997","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib19","first-page":"1000","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2005.04.005_bib20","first-page":"1008","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium","volume":"270","author":"Giovanni","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2005.04.005_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1471-4159.2003.01520.x","article-title":"Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells","volume":"84","author":"Gonzalez-Polo","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/275219a0","article-title":"Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity","volume":"275","author":"Hirata","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2005.04.005_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0024-3205(85)90062-1","article-title":"Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects","volume":"36","author":"Johannessen","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2005.04.005_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-2952(02)01179-6","article-title":"Lysophosphatidylcholine as a ligand for immunoregulation","volume":"64","author":"Kabarowski","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0005-2728(05)80332-9","article-title":"The effect of lysophosphatidylcholine on the activity of various mitochondrial enzymes","volume":"1098","author":"Kalous","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuro.2005.04.005_bib26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/mol.54.6.1046","article-title":"Protective effects of the anti-parkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells","volume":"54","author":"Kitamura","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib27","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1046\/j.1471-4159.1998.71062634.x","article-title":"Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity","volume":"7","author":"Klivenyi","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.59.6.612","article-title":"PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH","volume":"59","author":"Kukreja","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2005.04.005_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuro.2005.04.005_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0091-3057(01)00588-3","article-title":"1-Methyl-4-phenyl-pyridinium (MPP+) increases S-adenosyl-l-methionine dependent phospholipid methylation","volume":"70","author":"Lee","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2005.04.005_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neures.2003.11.010","article-title":"The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter","volume":"48","author":"Lee","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuro.2004.07.009","article-title":"Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats","volume":"26","author":"Lee","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2005.04.005_bib34","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0006-2952(03)00421-0","article-title":"Aggravation of l-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells","volume":"66","author":"Lee","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib35","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity","volume":"275","author":"Lotharius","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2005.04.005_bib36","first-page":"288","article-title":"Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig","volume":"115","author":"Maksem","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuro.2005.04.005_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.2042-7158.1992.tb05486.x","article-title":"Bile salt- and lysophosphatidylcholine-induced membrane damage in human erythrocytes","volume":"44","author":"Martin","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00006676-200101000-00014","article-title":"Lysophosphatidylcholine induces apoptosis in AR42J cells","volume":"22","author":"Masamune","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.neuro.2005.04.005_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0892-0362(02)00212-X","article-title":"N-methylation underlying Parkinson's disease","volume":"24","author":"Matsubara","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuro.2005.04.005_bib40","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0006-291X(89)91371-5","article-title":"A N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin N-methylisoquinolinium ion","volume":"161","author":"Naoi","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuro.2005.04.005_bib41","first-page":"197","article-title":"Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin","volume":"41","author":"Naoi","year":"1994","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2005.04.005_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(01)02238-7","article-title":"Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation","volume":"906","author":"Obata","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib43","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1016\/S0021-9258(18)68724-1","article-title":"Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction","volume":"263","author":"Oishi","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2005.04.005_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/1056-8719(95)00131-X","article-title":"Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions","volume":"35","author":"Palmeira","year":"1996","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuro.2005.04.005_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00218-0","article-title":"High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease","volume":"342","author":"Parsons","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2005.04.005_bib46","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2005.04.005_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/diabetes.43.7.915","article-title":"Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients","volume":"43","author":"Rabini","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.neuro.2005.04.005_bib48","first-page":"380","article-title":"MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies","volume":"268","author":"Rollema","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2005.04.005_bib49","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/jm00170a029","article-title":"In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species","volume":"33","author":"Rollema","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuro.2005.04.005_bib50","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/0006-2952(88)90674-0","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro","volume":"37","author":"Rossetti","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2005.04.005_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jnr.490430107","article-title":"Methyl phenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon","volume":"43","author":"Sawada","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000116779","article-title":"Influence of fatty acid content of lysophosphatidyl choline on its myelinotoxic properties","volume":"32","author":"Sedal","year":"1992","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neuro.2005.04.005_bib53","series-title":"Handbook of clinical neurology, disease of the basal ganglia","first-page":"173","article-title":"Parkinson's disease","author":"Selby","year":"1975"},{"key":"10.1016\/j.neuro.2005.04.005_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: Insights into parkinsonian neurodegeneration","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuro.2005.04.005_bib55","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1471-4159.1992.tb10080.x","article-title":"1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism","volume":"58","author":"Storey","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib56","first-page":"17","article-title":"Do environmental toxins cause Parkinson's disease? A critical review","volume":"40","author":"Tanner","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2005.04.005_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0361-9230(00)00427-5","article-title":"Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents","volume":"54","author":"Tariq","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuro.2005.04.005_bib58","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1471-4159.1992.tb08353.x","article-title":"Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form","volume":"59","author":"Thi\u00e8s","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.04.005_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-510X(79)90221-1","article-title":"Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum","volume":"44","author":"Waxman","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2005.04.005_bib61","first-page":"87","article-title":"Myelin lipids in ischemic stroke","volume":"29","author":"Wender","year":"1991","journal-title":"Neuropathol Pol"},{"key":"10.1016\/j.neuro.2005.04.005_bib62","first-page":"194","article-title":"N-methylation of pyridines and Parkinson's disease","volume":"60","author":"Williams","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuro.2005.04.005_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0169-328X(99)00103-5","article-title":"The toxicity of 6-hydroxydopamine on PC12 and P19 cells","volume":"69","author":"Woodgate","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(97)01551-5","article-title":"Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.","volume":"788","author":"Wright","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2005.04.005_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-2952(00)00304-X","article-title":"Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP (+)), and inhibition by epidermal growth factor in GH3 cells","volume":"60","author":"Yoshinaga","year":"2000","journal-title":"Biochem Pharmacol"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X05000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X05000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:52:53Z","timestamp":1706277173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X05000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0161813X05000367"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2005.04.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}